Media headlines about Patheon NV (NASDAQ:PTHN) have been trending somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Patheon NV earned a daily sentiment score of 0.22 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.0451224904397 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

PTHN has been the subject of several recent research reports. Zacks Investment Research raised Patheon NV from a “hold” rating to a “buy” rating and set a $39.00 price objective for the company in a research report on Saturday, June 10th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $35.00 target price on shares of Patheon NV in a research report on Friday, July 21st. Leerink Swann lowered shares of Patheon NV from an “outperform” rating to a “market perform” rating and increased their price target for the stock from $31.00 to $35.00 in a research note on Friday, June 9th. Raymond James Financial, Inc. reiterated a “market perform” rating and issued a $35.00 price target on shares of Patheon NV in a research note on Thursday, June 8th. Finally, J P Morgan Chase & Co cut shares of Patheon NV from an “overweight” rating to a “neutral” rating in a research report on Thursday, June 8th. One analyst has rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $34.50.

Patheon NV (PTHN) opened at 34.98 on Tuesday. Patheon NV has a 52-week low of $24.45 and a 52-week high of $35.02. The company has a market cap of $5.08 billion and a price-to-earnings ratio of 44.85. The company’s 50-day moving average price is $34.98 and its 200-day moving average price is $34.98.

COPYRIGHT VIOLATION WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at

Patheon NV Company Profile

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company’s segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products.

Insider Buying and Selling by Quarter for Patheon NV (NASDAQ:PTHN)

Receive News & Ratings for Patheon NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patheon NV and related companies with Analyst Ratings Network's FREE daily email newsletter.